NCT05679908Phase 2Completed

A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine

Study sponsor: Tonix Pharmaceuticals, Inc.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2023-10-08Actual
Enrollment · participants88Actual
Source updated2025-02-25Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview